p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non‐small Cell Lung Cancer

Although postoperative adjuvant therapy for non‐small cell lung cancer (NSCLC) had not been reported to be effective, it has been reported recently that oral administration of tegafur (1‐[2‐tetrahydrofuryl]‐5‐fluorouracil, FT) may improve the postoperative prognosis. In the present paper, to examine...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Jpn J Cancer Res
Päätekijät: Tanaka, Fumihiro, Yanagihara, Kazuhiro, Ohtake, Yohsuke, Miyahara, Ryou, Kawano, Youzou, Fukuse, Tatsuo, Hitomi, Shigeki, Wada, Hiromi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Publishing Ltd 1999
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926087/
https://ncbi.nlm.nih.gov/pubmed/10363582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1999.tb00766.x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia